Vyome Holdings HIND
NASDAQ HIND
$1.91 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vyome Holdings (HIND) Gains from Sales and Divestitures (2015 - 2023)

Updated

Vyome Holdings' Gains from Sales and Divestitures came in at $33,000 for FY2023, compared with -$529,000 in FY2022.

Analysis

Vyome Holdings (HIND) Gains from Sales and Divestitures (2015 - 2023) Analysis & Trends

Going back to FY2014, Vyome Holdings' Gains from Sales and Divestitures data covers 7 years.

  • The FY2023 figure represents the highest annual Gains from Sales and Divestitures in data going back to FY2014.
  • Per Business Quant, earlier years put Gains from Sales and Divestitures at -$529,000 in FY2022 and -$128,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vyome Holdings 13.41 Mn -12.70 Mn 11,658.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 33,000.00
Dec 31, 2022 -146,000.00
Sep 30, 2022 -1,000.00
Jun 30, 2022 -381,000.00
Sep 30, 2019 -33,000.00
Jun 30, 2019 -95,000.00
Mar 31, 2018 -107,000.00
Mar 31, 2016 -13,000.00
Dec 31, 2015 -17,000.00
API Access

Vyome Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=HIND&period=max&api_key=YOUR_API_KEY